Thus, retinoic acid receptor-α (RARα), whose expression is estrogen-regulated in breast cancer, localizes to ERα binding sites to modulate the expression of ERα target genes [10, 11], establishing crosstalk between estrogen and retinoid signalling that is important for the growth of ERα-positive breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.